Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 7/20 | 0.32 |
| ▸ | TAS1R1 | Q7RTX1 | 7/20 | 0.32 |
| ▸ | TAS1R2 | Q8TE23 | 7/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL107094 | 0.95 | TAS1R3 (0.33) | TAS1R3TAS1R1TAS1R2 | |
| SCHEMBL12170037 | 0.91 | TAS1R3 (0.32) | TAS1R3TAS1R1TAS1R2 | |
| SCHEMBL926802 | 0.91 | TAS1R3 (0.35) | TAS1R3TAS1R1TAS1R2 | |
| SCHEMBL1998603 | 0.91 | — | — | |
| Water SCHEMBL22129214 | 0.86 | TAS1R3 (0.33) | TAS1R3TAS1R1TAS1R2 | |
| Ammonia Solution, Strong SCHEMBL12487556 | 0.86 | TAS1R3 (0.33) | TAS1R3TAS1R1TAS1R2 | |
| Bromide SCHEMBL9813323 | 0.86 | TAS1R3 (0.33) | TAS1R3TAS1R1TAS1R2 | |
| Bromide SCHEMBL9813316 | 0.86 | TAS1R3 (0.33) | TAS1R3TAS1R1TAS1R2 | |
| SCHEMBL3043216 | 0.86 | — | — | |
| SCHEMBL12140663 | 0.84 | TAS1R3 (0.30) | TAS1R3TAS1R1TAS1R2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240224783-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2024-07-04 | — | — | US | disclosed |
| US-20240218004-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2024-07-04 | — | — | US | disclosed |
| US-20240224782-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2024-07-04 | — | — | US | disclosed |
| US-20240209013-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2024-06-27 | — | — | US | disclosed |
| WO-2024133779-A1 | SUBSTITUTED TRIANGLAMINE AND USES THEREOF | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2024-06-27 | — | — | WO | disclosed |
| EP-4389263-A1 | SUBSTITUTED TRIANGLAMINE AND USES THEREOF | Centre national de la recherche scientifique (FR) | 2024-06-26 | — | — | EP | disclosed |
| WO-2024096610-A1 | INK COMPOSITION, ORGANIC MATERIAL LAYER COMPRISING SAME, AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2024-05-10 | — | — | WO | disclosed |
| US-20240023435-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2024-01-18 | — | — | US | disclosed |
| US-20230399350-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-12-14 | — | — | US | disclosed |
| WO-2023223990-A1 | PORE FILLING MEMBRANE, FUEL CELL, AND ELECTROLYSIS DEVICE | 国立大学法人東京工業大学 | 2023-11-23 | — | — | WO | disclosed |
| US-7364771-B2 | Method and apparatus for production of fluorine-containing polyimide film | NIPPON SHOKUBAI CO., LTD. (JP) | 2008-04-29 | — | — | US | disclosed |
| US-7364771-B2 | Method and apparatus for production of fluorine-containing polyimide film | NIPPON SHOKUBAI CO., LTD. (JP) | 2008-04-29 | — | — | US | disclosed |
| US-7259229-B2 | Electroactive fluorene polymers having perfluoralkyl groups, process for preparing such polymers and devices made with such polymers | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-08-21 | — | — | US | disclosed |
| US-7259229-B2 | Electroactive fluorene polymers having perfluoralkyl groups, process for preparing such polymers and devices made with such polymers | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-08-21 | — | — | US | disclosed |
| WO-2007088181-A1 | NOVEL DUAL NK2/NK3-ANTAGONISTS, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND PROCESSES FOR THEIR PREPARATIONS | SOLVAY PHARMACEUTICALS GMBH (DE) | 2007-08-09 | — | — | WO | disclosed |
| US-7211643-B2 | Electroactive fluorene copolymers and devices made with such polymers | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-05-01 | — | — | US | disclosed |
| US-20070083015-A1 | Modified poly(ethynylene phenylene ethynylene silylene) polymers, compositions containing them, processing for preparing them and cured products | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2007-04-12 | — | — | US | disclosed |
| US-7183365-B2 | Electroactive fluorene polymers having perfluoroalkyl groups, process for preparing such polymers and devices made with such polymers | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-02-27 | — | — | US | disclosed |
| US-7183366-B2 | Aromatic copolymers from dihalofluorene compounds and another dihalo- or diborono- aromatic monomers; organic electroluminescent polymers for use in light-emitting diodes | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-02-27 | — | — | US | disclosed |
| US-20070043095-A1 | Derivatives of 2-arylimino-2,3-dihydrothiazoles, their preparation processes and their therapeutic use | IPSEN PHARMA S.A.S. (FR) | 2007-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230399350-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, OSBP | TAS1R3 2358/4885TAS1R1 2689/4885TAS1R2 2621/4885 |
| US-20070043095-A1 | Derivatives of 2-arylimino-2,3-dihydrothiazoles, their preparation processes and their therapeutic use | SSTR2, SSTR5, SSTR3 | TAS1R3 530/4885TAS1R1 504/4885TAS1R2 389/4885 |
| US-20240224783-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, ICOSLG | TAS1R3 1885/4885TAS1R1 1781/4885TAS1R2 1708/4885 |
| US-20240209013-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, SSB, L1CAM | TAS1R3 2513/4885TAS1R1 1756/4885TAS1R2 1537/4885 |
| US-20240224782-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | RER1, OCIAD2, OCIAD1 | TAS1R3 2557/4885TAS1R1 1038/4885TAS1R2 1388/4885 |
| US-20240218004-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, CCND2 | TAS1R3 3869/4885TAS1R1 2389/4885TAS1R2 2717/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.